Administration of antivirals, IL-6 inhibitors, monoclonal neutralizing antibodies and systemic corticosteroids in acute SARS-CoV-2 infection do not reduce the subsequent burden of Long-COVID symptoms
Floridia et al., Le Infezioni in Medicina, doi:10.53854/liim-3304-4
https://c19early.org/floridia.html